General Spectrum of Activity
Antimicrobial Category II
Mechanisms of Resistance
Feline Dosing
5-8 mg/kg IV/IM/SQ q24h
Canine Dosing
9-12 mg/kg IV/IM/SC q24h
CLSI breakpoint for Enterobacterales and Pseudomonas based on 10 mg/kg IM q24h
Common Usage
Monitoring
Pharmacology & Pharmacokinetics
Adverse Effects & Warnings
Major Interactions
Additional Information
No approved parenteral products for dogs and cats in Canada.
Client Information
Cats may be more sensitive to toxic effects.
Key Resources